OSSIO Closes Series C Financing of $38.5 Million

OSSIO OSSIOfiber Technology

OSSIO has closed $38.5 million in Series C financing. The additional funding will support further adoption of OSSIOfiber® Intelligent Bone Regeneration Technology with new product development, sales force expansion, patient outreach and medical education.

All OSSIO implants are made with OSSIOfiber Intelligent Bone Regeneration Technology, a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us